Published in Managed Care Business Week, August 21st, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at St. Jude Medical, Inc.
Report 1: St. Jude Medical, Inc. (NYSE:STJ) announced CE Mark approval of its new OptiSense(TM) lead, a first-of-its-kind pacing lead designed to offer more accurate sensing in the upper chamber of the heart (right atrium). The lead, which will be introduced at the Europace 2007 Meeting in Lisbon, Portugal, incorporates a new tip design that increases the device's ability to detect and classify electrical signals in the atrium more accurately by avoiding picking up...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Managed Care Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.